Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

West Pharmaceutical Services (WST)

West Pharmaceutical Services (WST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 20,271,378
  • Shares Outstanding, K 71,943
  • Annual Sales, $ 2,893 M
  • Annual Income, $ 492,700 K
  • EBIT $ 588 M
  • EBITDA $ 743 M
  • 60-Month Beta 1.17
  • Price/Sales 7.07
  • Price/Cash Flow 31.55
  • Price/Book 6.70

Options Overview Details

View History
  • Implied Volatility 25.27% (-0.55%)
  • Historical Volatility 31.61%
  • IV Percentile 2%
  • IV Rank 0.26%
  • IV High 68.27% on 04/07/25
  • IV Low 25.16% on 08/25/25
  • Expected Move (DTE 14) 8.84 (3.14%)
  • Put/Call Vol Ratio 0.07
  • Today's Volume 32
  • Volume Avg (30-Day) 169
  • Put/Call OI Ratio 0.77
  • Today's Open Interest 6,373
  • Open Int (30-Day) 6,364
  • Expected Range 272.93 to 290.61

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 1.83
  • Number of Estimates 5
  • High Estimate 1.88
  • Low Estimate 1.77
  • Prior Year 1.82
  • Growth Rate Est. (year over year) +0.55%

Price Performance

See More
Period Period Low Period High Performance
1-Month
253.32 +11.50%
on 11/20/25
285.55 -1.08%
on 11/06/25
-1.09 (-0.38%)
since 11/05/25
3-Month
248.88 +13.49%
on 09/08/25
322.34 -12.37%
on 10/23/25
+31.72 (+12.65%)
since 09/05/25
52-Week
187.43 +50.70%
on 04/09/25
348.90 -19.04%
on 01/28/25
-35.75 (-11.23%)
since 12/05/24

Most Recent Stories

More News
1 Healthcare Stock with Promising Prospects and 2 We Question

1 Healthcare Stock with Promising Prospects and 2 We Question

MYGN : 7.20 (-1.77%)
WST : 280.13 (-0.58%)
ISRG : 575.60 (+1.23%)
Option Care Health, DaVita, Revvity, West Pharmaceutical Services, and Bausch + Lomb Shares Skyrocket, What You Need To Know

Option Care Health, DaVita, Revvity, West Pharmaceutical Services, and Bausch + Lomb Shares Skyrocket, What You Need To Know

OPCH : 29.98 (+0.27%)
BLCO : 17.07 (+1.55%)
WST : 280.13 (-0.58%)
DVA : 117.72 (+0.38%)
RVTY : 101.74 (-0.79%)
What Are Wall Street Analysts' Target Price for West Pharmaceutical Services Stock?

West Pharmaceutical Services has substantially underperformed the broader market over the past year, yet analysts remain bullish on the stock’s prospects, with price targets suggesting significant upside...

XLV : 154.24 (+0.22%)
$SPX : 6,870.96 (+0.20%)
WST : 280.13 (-0.58%)
These 3 High-Rated Dividend Aristocrats Passed Every Barchart Technical Test

Discover 3 top Dividend Aristocrats with strong buy ratings and bullish technical signals. See how Barchart’s Opinion helps you find high-quality income stocks with real upside.

KO : 70.55 (+0.14%)
WST : 280.13 (-0.58%)
NUE : 161.40 (-0.70%)
WMT : 115.30 (+0.40%)
Winners And Losers Of Q3: West Pharmaceutical Services (NYSE:WST) Vs The Rest Of The Drug Development Inputs & Services Stocks

Winners And Losers Of Q3: West Pharmaceutical Services (NYSE:WST) Vs The Rest Of The Drug Development Inputs & Services Stocks

WST : 280.13 (-0.58%)
Biologics Market Surges Toward $680B as FDA Accelerates Approval Pathways

Issued on behalf of Avant Technologies Inc. VANCOUVER – Baystreet.ca News Commentary – The global biologics industry is experiencing unprecedented expansion as the market surges toward $679.56...

AVAI : 0.2950 (-0.03%)
VRTX : 460.84 (+0.76%)
WST : 280.13 (-0.58%)
RCKT : 3.43 (+0.29%)
AXSM : 149.99 (+1.32%)
1 High-Flying Stock on Our Watchlist and 2 Facing Challenges

1 High-Flying Stock on Our Watchlist and 2 Facing Challenges

WWD : 302.88 (+0.41%)
WST : 280.13 (-0.58%)
PANW : 197.69 (+1.03%)
The 5 Most Interesting Analyst Questions From West Pharmaceutical Services’s Q3 Earnings Call

The 5 Most Interesting Analyst Questions From West Pharmaceutical Services’s Q3 Earnings Call

WST : 280.13 (-0.58%)
West Synchronyâ„¢ Prefillable Syringe System Launches at CPHI: Redefining a system-level solution for drug delivery

EXTON, Pa. , Oct. 27, 2025 /PRNewswire/ --  West Pharmaceutical Services, Inc.  (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the...

WST : 280.13 (-0.58%)
West to Participate in Upcoming Investor Conferences

EXTON, Pa. , Oct. 24, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it will...

WST : 280.13 (-0.58%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical...

See More

Key Turning Points

3rd Resistance Point 295.69
2nd Resistance Point 290.62
1st Resistance Point 286.19
Last Price 280.13
1st Support Level 276.69
2nd Support Level 271.62
3rd Support Level 267.19

See More

52-Week High 348.90
Fibonacci 61.8% 287.22
Last Price 280.13
Fibonacci 50% 268.16
Fibonacci 38.2% 249.11
52-Week Low 187.43

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar